WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
FONR
FONAR CORP
$21.790.37%-1.98%-5.43%10.44%38.09%41.49%19.99%-0.37%27.95%$24.05$12.139.40%79.64%0.616,175-41.04%
STRR
STAR EQUITY HOLDINGS INC
$0.900.45%-2.40%-5.79%-13.94%-9.60%17.15%-71.13%-90.13%-97.29%$1.59$0.6543.71%37.48%0.5258,12912.64%
IDXX
IDEXX LABORATORIES INC
$539.571.69%1.90%-6.17%-3.15%23.51%10.33%12.60%146.56%787.82%$583.39$372.507.51%44.85%1.04307,414-22.78%
ICLR
ICON PLC
$329.50-0.12%-1.86%2.18%15.95%32.83%58.50%70.40%148.27%603.31%$344.77$181.924.43%81.12%0.96541,10822.44%
RVTY
REVVITY INC
$105.411.92%0.71%-0.21%-4.77%-3.34%-17.65%-18.06%11.72%137.78%$139.04$79.5024.19%32.59%0.881,221,86379.12%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$269.371.48%0.45%6.49%12.78%38.18%36.42%-4.80%90.72%352.42%$275.00$161.652.05%66.64%1.16288,817-8.26%
MEDP
MEDPACE HOLDINGS INC
$403.270.13%1.06%-0.08%29.26%62.61%120.05%148.67%606.50%N/A$419.42$181.503.85%122.19%1.23101,929-34.03%
QGEN
QIAGEN NV
$42.750.12%-2.73%-1.70%-4.63%5.06%-10.61%-14.29%3.59%92.72%$49.18$35.8113.07%19.37%0.421,012,9759.82%
SHC
SOTERA HEALTH CO
$11.872.95%0.76%-31.55%-31.23%-21.18%-32.33%-50.60%N/AN/A$19.40$10.7438.81%10.52%1.241,698,403-28.85%
TMO
THERMO FISHER SCIENTIFIC INC
$579.371.85%-0.12%2.33%8.98%16.27%3.15%26.34%115.50%392.37%$603.82$415.604.05%39.41%0.831,521,372-12.98%
ENZ
ENZO BIOCHEM INC
$1.271.60%4.10%-5.22%-7.30%-7.97%-43.30%-60.68%-52.79%-67.85%$2.74$1.1653.65%9.48%0.4687,181-1.22%
A
AGILENT TECHNOLOGIES INC
$147.372.05%0.06%11.18%5.40%33.37%10.75%17.50%86.54%169.46%$151.58$96.802.78%52.24%0.971,208,890-40.17%
LH
LABORATORY CORP OF AMERICA HOLDINGS
$216.571.43%3.44%0.41%-4.45%5.72%-1.46%-13.92%43.51%121.28%$243.30$195.0110.99%11.06%0.91430,692-22.97%
CSTL
CASTLE BIOSCIENCES INC
$21.28-1.44%4.57%-15.19%-3.84%29.84%-5.97%-63.88%N/AN/A$26.70$9.2620.30%129.81%1.12155,310-25.87%
DHR
DANAHER CORP
$248.770.12%-1.16%-2.39%6.83%0.54%0.32%9.65%91.75%238.74%$269.61$182.097.73%36.62%0.852,656,35635.36%
TWST
TWIST BIOSCIENCE CORP
$34.482.16%-2.63%-15.88%-9.83%67.87%111.79%-67.87%58.17%N/A$43.21$11.4620.20%200.87%1.71505,101-20.71%
NEOG
NEOGEN CORP
$15.463.07%-0.90%-10.48%-24.77%-16.48%-15.52%-63.67%-44.30%-7.73%$24.10$14.4435.84%7.10%1.001,101,026-17.20%
DGX
QUEST DIAGNOSTICS INC
$131.061.70%2.62%3.66%-4.74%6.21%-6.00%2.36%48.07%126.43%$148.62$119.5911.82%9.59%0.61752,82513.00%
WAT
WATERS CORP
$345.192.10%-0.91%3.77%3.65%26.75%14.02%21.54%39.91%220.18%$363.80$231.905.12%48.85%0.91439,45019.75%
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,335.841.58%2.53%10.11%9.23%21.69%-9.83%14.12%90.10%477.81%$1.62k$928.5017.34%43.87%1.0187,569-18.39%
XGN
EXAGEN INC
$1.561.30%-3.11%-20.81%-22.00%-38.34%-32.29%-91.22%N/AN/A$3.92$1.3360.23%17.29%1.3447,620-1.25%
SERA
SERA PROGNOSTICS INC
$9.46-0.42%4.88%6.29%49.45%405.88%148.29%N/AN/AN/A$10.44$1.529.39%522.37%0.73396,702-7.37%
IQV
IQVIA HOLDINGS INC
$252.571.95%-0.06%1.50%8.90%24.90%32.30%32.24%78.94%404.53%$261.73$167.423.50%50.86%1.19724,695-17.11%
NTRA
NATERA INC
$90.460.51%-2.63%18.78%47.76%94.04%61.56%-1.10%397.58%N/A$96.24$36.906.01%145.15%1.381,617,18516.75%
EXAS
EXACT SCIENCES CORP
$66.882.51%6.73%17.54%-11.63%-0.86%0.09%-44.19%-18.99%386.40%$100.77$56.0533.63%19.32%1.311,670,460-12.99%
PSNL
PERSONALIS INC
$1.451.40%-3.97%-3.33%-28.57%17.89%-44.44%-93.00%N/AN/A$3.27$0.8955.66%62.74%1.59205,42919.04%
DRIO
DARIOHEALTH CORP
$1.520.33%8.57%-29.30%-10.06%-53.23%-62.47%-92.10%-89.73%-99.95%$4.58$0.6866.81%123.53%1.13139,779282.85%
OLK
OLINK HOLDING AB (PUBL)
$23.60-1.91%-2.44%4.75%-6.35%60.33%9.31%-26.02%N/AN/A$26.01$14.109.27%67.38%1.53421,491-47.07%
ACRS
ACLARIS THERAPEUTICS INC
$1.266.78%5.88%5.00%18.87%-81.08%-84.52%-94.40%-78.93%N/A$11.12$0.5988.67%113.56%1.031,286,13180.36%
FLGT
FULGENT GENETICS INC
$21.690.28%-1.32%-14.87%-28.06%-20.23%-30.90%-77.91%296.02%N/A$44.09$21.2350.81%2.17%1.27173,74215.15%
GH
GUARDANT HEALTH INC
$17.961.53%0.17%-8.04%-35.90%-34.97%-26.18%-87.04%-75.35%N/A$41.06$16.9256.26%6.18%1.342,741,75452.19%
DMTK
DERMTECH INC
$0.719.08%2.60%-47.87%-62.29%-53.66%-78.84%-98.41%-96.36%N/A$4.67$0.6284.82%13.80%1.23432,11343.15%
STIM
NEURONETICS INC
$4.800.84%11.63%47.69%76.47%258.21%63.82%-58.55%-67.46%N/A$4.99$1.033.81%366.02%1.29140,008-12.49%
NEO
NEOGENOMICS INC
$15.200.26%-2.19%-5.77%-25.85%22.38%-12.34%-65.54%-20.42%340.58%$21.22$11.0328.37%37.81%1.42787,191-2.66%
RDNT
RADNET INC
$48.490.37%2.71%26.47%34.92%69.66%102.55%117.35%297.79%1,689.30%$49.41$23.851.86%103.31%1.34657,769-0.24%
BGLC
BIONEXUS GENE LAB CORP
$0.700.29%-11.84%-1.41%27.27%-13.58%N/A-66.67%N/AN/A$9.49$0.3192.62%125.81%7.1625,915-59.89%
APDN
APPLIED DNA SCIENCES INC
$0.43-1.83%-14.40%-27.70%-30.97%-65.20%-61.09%-93.95%-98.02%-99.86%$1.86$0.3776.99%16.30%0.2262,574-22.91%
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.08-0.48%7.22%0.97%27.61%80.87%13.66%N/AN/AN/A$3.62$0.9642.54%117.80%1.0749,776-33.45%
PRPO
PRECIPIO INC
$6.201.97%3.06%-4.55%-4.70%4.62%-52.28%-86.09%-83.10%-99.98%$15.41$4.7559.74%30.56%0.723,333429.89%
NDRA
ENDRA LIFE SCIENCES INC
$0.82-15.81%-20.39%-28.38%-58.59%-23.36%-69.40%-98.24%-98.62%N/A$2.91$0.8071.82%2.37%0.88320,60689.09%
MDXH
MDXHEALTH SA
$2.46-1.20%-1.60%-34.40%-38.50%-12.14%-13.68%N/AN/AN/A$4.64$2.1546.98%14.42%0.4143,84340.32%
BNR
BURNING ROCK BIOTECH LTD
$0.700.00%1.45%-12.72%-26.32%-24.08%-75.48%-97.29%N/AN/A$3.25$0.5778.46%22.38%0.99102,20922.10%
CDNA
CAREDX INC
$10.529.93%4.99%10.85%-17.17%42.74%15.86%-82.49%-68.69%N/A$12.93$4.8018.64%119.17%1.51743,07828.75%
BDSX
BIODESIX INC
$1.44-0.69%6.67%-8.86%-20.88%-6.49%-16.76%-91.46%N/AN/A$2.21$1.0334.84%39.81%1.1230,254-30.47%
GTH
GENETRON HOLDINGS LTD
$4.020.00%3.88%2.55%9.24%67.50%34.00%-92.93%N/AN/A$4.03$2.080.25%93.27%0.9149,808-29.44%
LAB
STANDARD BIOTOOLS INC
$2.691.89%2.67%14.96%22.27%-5.94%32.51%-37.88%-79.65%-93.47%$3.16$1.4614.87%84.25%1.301,444,631-15.16%
CHEK
CHECK-CAP LTD
$2.7511.34%33.43%22.77%25.00%-38.89%102.95%-91.96%-95.02%N/A$4.63$1.2540.54%120.00%0.55656,853-95.00%
PRPH
PROPHASE LABS INC
$6.26-0.48%13.20%24.45%35.21%43.25%-23.28%1.13%93.21%213.00%$9.94$4.0537.03%54.57%0.2832,531-33.96%
XWEL
XWELL INC
$1.70-1.16%-8.60%-17.07%3.66%-30.10%-77.03%-95.00%-99.05%-100.00%$7.54$1.2677.45%34.92%1.1823,49258.88%
OPK
OPKO HEALTH INC
$1.075.94%20.22%1.90%-32.28%-31.41%-18.94%-74.82%-56.50%-88.18%$2.24$0.8552.23%25.59%1.2111,798,948229.31%
NOTV
INOTIV INC
$10.656.08%10.71%61.12%217.91%248.04%130.02%-43.50%435.18%327.71%$11.42$1.616.72%561.49%1.08282,020-53.25%
ME
23ANDME HOLDING CO
$0.514.51%8.05%-23.08%-43.46%-48.22%-77.33%-94.96%N/AN/A$2.32$0.4078.02%27.18%1.664,839,060-24.19%
PMD
PSYCHEMEDICS CORP
$3.000.00%2.04%-1.64%3.63%-19.14%-43.18%-52.38%-79.35%-82.83%$5.63$2.0646.71%45.63%0.473,15215.92%
VNRX
VOLITIONRX LTD
$0.74-0.93%-7.13%-24.95%4.94%2.48%-56.80%-78.40%-75.64%-71.42%$2.10$0.5564.62%35.09%0.97574,12826.69%
GENE
GENETIC TECHNOLOGIES LTD
$2.813.69%4.42%44.85%19.07%-96.50%-97.60%-99.29%-99.23%-99.91%$120.00$1.8097.66%56.11%0.6835,8619.35%
MYGN
MYRIAD GENETICS INC
$21.40-0.42%-3.78%-8.94%8.19%31.53%-8.19%-25.93%-38.26%-35.87%$24.21$13.8211.61%54.85%1.37505,033-7.97%
ISPC
ISPECIMEN INC
$0.256.36%-16.33%-42.95%-49.29%-58.85%-81.27%N/AN/AN/A$2.05$0.2087.73%24.88%0.74450,77718.59%
PRE
PRENETICS GLOBAL LTD
$3.570.28%-24.04%-26.39%-37.37%-50.19%-68.27%N/AN/AN/A$16.50$3.2578.36%10.02%0.53121,010-25.07%
ILMN
ILLUMINA INC
$138.683.65%4.12%-0.77%-2.70%4.04%-36.33%-64.89%-54.09%-3.00%$233.42$89.0040.59%55.82%1.10935,956-16.81%
OCX
ONCOCYTE CORP
$2.98-0.60%-2.93%0.68%19.20%-4.79%-46.40%-96.61%-96.02%N/A$7.40$2.0859.73%43.27%1.211,766-84.15%
AWH
ASPIRA WOMEN's HEALTH INC
$3.43-2.00%-1.29%-15.31%-9.02%-36.83%-36.98%-96.52%-81.99%-92.60%$6.75$2.3149.19%48.55%0.9424,75815.38%
CNTG
CENTOGENE NV
$0.690.00%1.47%-10.39%-42.98%-36.11%-4.17%-93.87%N/AN/A$2.52$0.6072.62%15.00%0.38781,5603,698.96%
TRIB
TRINITY BIOTECH PLC
$1.98-1.98%-10.00%-13.91%1.54%-44.37%-55.51%-90.27%-85.33%-98.29%$6.20$1.8568.06%7.03%0.3612,359-47.04%
TTOO
T2 BIOSYSTEMS INC
$3.056.64%-1.93%-42.45%-40.89%-83.14%-93.85%-99.96%-99.98%N/A$70.00$2.7095.64%12.96%1.09267,32042.17%
MYNZ
MAINZ BIOMED NV
$0.99-1.98%-9.17%9.88%-16.10%-68.06%-84.67%N/AN/AN/A$6.70$0.8585.22%16.47%0.7215,850-70.68%

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Mar 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the top diagnostic & research stock with a Zen Score of 47, which is 19 points higher than the diagnostic & research industry average of 28. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 41.49% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

2. Idexx Laboratories (NASDAQ:IDXX)


Idexx Laboratories (NASDAQ:IDXX) is the second best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 15 out of 33 due diligence checks and has strong fundamentals. Idexx Laboratories has seen its stock return 10.33% over the past year, overperforming other diagnostic & research stocks by 7 percentage points.

Idexx Laboratories has an average 1 year price target of $584.00, an upside of 8.23% from Idexx Laboratories's current stock price of $539.57.

Idexx Laboratories stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Idexx Laboratories, 60% have issued a Strong Buy rating, 0% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the third best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 58.5% over the past year, overperforming other diagnostic & research stocks by 55 percentage points.

Icon has an average 1 year price target of $335.71, an upside of 1.89% from Icon's current stock price of $329.50.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Icon, 71.43% have issued a Strong Buy rating, 28.57% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.99%, which is 1 percentage points higher than the diagnostic & research industry average of 1.6%.

Qiagen Nv's dividend payout ratio of 85.3% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.17%, which is 1 percentage points higher than the diagnostic & research industry average of 1.6%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 37.4% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.33%, which is the same as the diagnostic & research industry average of 1.6%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 60% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 1.4% in the last day, and up 0.98% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are up.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 17.15% in the past year. It has overperformed other stocks in the diagnostic & research industry by 14 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -43.3% in the past year. It has underperformed other stocks in the diagnostic & research industry by -47 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 49 points higher than the diagnostic & research industry average of 22. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 41.49% in the past year. It has overperformed other stocks in the diagnostic & research industry by 38 percentage points.

Are diagnostic & research stocks a good buy now?

45.24% of diagnostic & research stocks rated by analysts are a buy right now. On average, analysts expect diagnostic & research stocks to rise by 0.63% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 37.3x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.